Status:
COMPLETED
ENDOCUR - Modulation of Endotoxaemia Via Curcumin Intake in Healthy Overweight Adults
Lead Sponsor:
University of Glasgow
Conditions:
Overweight
Eligibility:
All Genders
18-45 years
Phase:
NA
Brief Summary
Chronic diseases such as diabetes, cardiovascular diseases and cancer are a major burden on the Scottish population. Obesity and inflammation have strong links to these diseases. One of the mechanisms...
Eligibility Criteria
Inclusion
- \- BMI \> 25 kg/m2.
Exclusion
- having chronic inflammatory or autoimmune disease, gastrointestinal complaints or known biliary obstruction (past and present)
- use of anti-inflammatory drugs 2 weeks before the start of the study
- use of antibiotics during the 12 weeks preceding the trial
- pregnancy
- lactation
Key Trial Info
Start Date :
February 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2018
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT03329781
Start Date
February 1 2015
End Date
January 1 2018
Last Update
April 30 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.